Noxopharm (ASX:NOX) Ending Cash Position : A$5.16 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Noxopharm Ending Cash Position?

Noxopharm's Ending Cash Position for the quarter that ended in Dec. 2023 was A$5.16 Mil.

Noxopharm's quarterly Ending Cash Position declined from Dec. 2022 (A$11.12 Mil) to Jun. 2023 (A$3.01 Mil) but then increased from Jun. 2023 (A$3.01 Mil) to Dec. 2023 (A$5.16 Mil).

Noxopharm's annual Ending Cash Position declined from Jun. 2021 (A$26.80 Mil) to Jun. 2022 (A$14.01 Mil) and declined from Jun. 2022 (A$14.01 Mil) to Jun. 2023 (A$3.01 Mil).

Noxopharm Ending Cash Position Historical Data

The historical data trend for Noxopharm's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noxopharm Ending Cash Position Chart

Noxopharm Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Ending Cash Position

Get a 7-Day Free Trial

2.91

7.10

26.80

14.01

3.01

Noxopharm Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial										16.69	14.01	11.12	3.01	5.16

Noxopharm Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Noxopharm's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	14.01	+	-11.001
	=	3.01

Noxopharm's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3.012	+	2.148
	=	5.16

Noxopharm Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Noxopharm's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Noxopharm (ASX:NOX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

NOXOF:USA

Address

60 Linksley Ave, Glenhaven, NSW, AUS, 2156

Website

https://www.noxopharm.com

Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.

Noxopharm (ASX:NOX) Headlines

No Headlines